• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Reports Third Quarter Financial Results

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year —

    • Q3'25 Revenue of $42.9 million, up 57% year-over-year
    • Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year
    • Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)%
    • Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12%

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025.

    "We made meaningful progress across many key measures of the business in the third quarter—including subscribers, revenue, and annual recurring revenue, as well as important indicators of profitability and liquidity," said John Kedzierski, President and Chief Executive Officer of Evolv Technology. "Through strong new customer acquisition and expanding deployments with existing customers, we continue to deliver real-world impact at scale—screening millions of visitors every day across over 1,000 customers. Looking ahead, we're encouraged by the growing demand for our solutions and are confident in our ability to close the year with momentum as we advance on our goal of building a high-growth, profitable, and cash-generative business."

    Results for the Third Quarter of 2025

    Total revenue for the third quarter of 2025 was $42.9 million, an increase of 57% compared to $27.4 million for the third quarter of 2024. Revenue for the third quarter of 2025 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Revenue for the period also reflected certain notable items that contributed approximately $7.5 million from the following: (i) approximately $3.0 million of revenue (primarily product revenue) associated with the largest customer order in the Company's history; (ii) approximately $3.0 million attributable to IP license fees and other revenue associated with the Company's distribution fulfillment model which is being phased out; and (iii) approximately $1.5 million from short-term rental agreements that concluded in the period. Annual Recurring Revenue ("ARR")1 was $117.2 million at the end of third quarter of 2025, an increase of 25% compared to $93.7 million at the end of the third quarter of 2024. Net loss for the third quarter of 2025 was $(1.8) million, or $(0.01) per basic and diluted share, compared to $(30.4) million, or $(0.19) per basic and diluted share, in the third quarter of 2024. Adjusted earnings (loss)2 for the third quarter of 2025 was $(3.4) million, or $(0.02) per diluted share, compared to adjusted earnings (loss)2 of $(6.9) million, or $(0.04) per diluted share (as restated), for the third quarter of 2024. Adjusted EBITDA2 for the third quarter of 2025 was $5.1 million compared to $(3.0) million in the third quarter of 2024. As of September 30, 2025, the Company had cash, cash equivalents and marketable securities of $56.2 million.

    Results for the First Nine Months of 2025

    Total revenue for the nine months ended September 30, 2025 was $107.4 million, an increase of 44% compared to $74.8 million for the nine months ended September 30, 2024. Net loss for the nine months ended September 30, 2025 was $(44.0) million, or $(0.26) per basic and diluted share, compared to $(38.3) million, or $(0.25) per basic and diluted share, in the nine months ended September 30, 2024. Adjusted earnings (loss)2 for the nine months ended September 30, 2025 was $(11.5) million, or $(0.07) per diluted share, compared to adjusted earnings (loss)2 of $(30.8) million, or $(0.20) per diluted share, for the nine months ended September 30, 2024. Adjusted EBITDA2 for the nine months ended September 30, 2025 was $9.3 million compared to $(21.3) million in the nine months ended September 30, 2024.

    The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

    2024

     

    % Change

     

     

    2025

     

     

    2024

     

    % Change

    Recurring revenue

    $

    30,120

     

    $

    23,764

     

    27

    %

     

    $

    82,551

     

    $

    63,741

     

    30

    %

    Non-recurring revenue

     

    12,730

     

     

    3,596

     

    254

    %

     

     

    24,850

     

     

    11,024

     

    125

    %

    Total revenue

    $

    42,850

     

    $

    27,360

     

    57

    %

     

    $

    107,401

     

    $

    74,765

     

    44

    %

    The following table summarizes operating cash flows for each period presented:

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

    Net loss

    $

    (44,020

    )

     

    $

    (38,297

    )

    Adjustments to reconcile net loss to net cash provided by (used in) operating activities

     

    44,660

     

     

     

    15,634

     

    Changes in operating assets and liabilities

     

    2,458

     

     

     

    (11,394

    )

    Net cash provided by (used in) operating activities

    $

    3,098

     

     

    $

    (34,057

    )

    Company Comments on Outlook for 2025

    The Company today commented on its business outlook for 2025. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2025 to be between $142 to $145 million, reflecting growth of 37% to 40% compared to 2024. The Company believes that this revenue growth, coupled with a focus on operational efficiency, will drive improved profitability and cash flow. The Company expects to deliver positive full year Adjusted EBITDA1 in 2025 with Adjusted EBITDA1 margins in the high single digits. The Company expects to be cash flow positive in the fourth quarter of 2025.

    Estimate

     

    Issued August 14, 2025

     

    Issued November 13, 2025

    Total Revenue (Millions)

     

    $132-$135

     

    $142-$145

    Total Revenue Growth Rate

     

    27%-30%

     

    37%-40%

    Adjusted EBITDA Margin2

     

    Mid-Single Digits

     

    High Single Digits

    Company to Host Live Conference Call and Webcast

    The Company's management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management's outlook for the business for both 2025 and 2026. The conference call will be webcast live at http://ir.evolvtechnology.com.

    About Evolv Technology

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than three billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

    1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    2 Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, non-recurring employee restructuring and other separation costs, and non-recurring inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the U.S. Federal Trade Commission investigation, net of estimated insurance recoveries. Adjusted operating income (loss), is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, demand for our products, market opportunities, and future financial and operational results. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "project," "plan," "target," "forecast", "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the "SEC") and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company's reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on From 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

    You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    9,242

     

     

    $

    1,344

     

     

    $

    14,092

     

     

    $

    4,789

     

    Subscription revenue

     

    22,685

     

     

     

    17,909

     

     

     

    62,122

     

     

     

    47,783

     

    Service revenue

     

    7,808

     

     

     

    6,085

     

     

     

    21,224

     

     

     

    16,903

     

    License fee and other revenue

     

    3,115

     

     

     

    2,022

     

     

     

    9,963

     

     

     

    5,290

     

    Total revenue

     

    42,850

     

     

     

    27,360

     

     

     

    107,401

     

     

     

    74,765

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    7,960

     

     

     

    2,616

     

     

     

    16,495

     

     

     

    8,569

     

    Cost of subscription revenue

     

    10,923

     

     

     

    7,348

     

     

     

    27,713

     

     

     

    19,242

     

    Cost of service revenue

     

    2,338

     

     

     

    1,404

     

     

     

    5,753

     

     

     

    3,749

     

    Cost of license fee and other revenue

     

    323

     

     

     

    183

     

     

     

    766

     

     

     

    484

     

    Total cost of revenue

     

    21,544

     

     

     

    11,551

     

     

     

    50,727

     

     

     

    32,044

     

    Gross profit

     

    21,306

     

     

     

    15,809

     

     

     

    56,674

     

     

     

    42,721

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    5,608

     

     

     

    5,810

     

     

     

    15,207

     

     

     

    18,056

     

    Sales and marketing

     

    11,715

     

     

     

    14,966

     

     

     

    34,494

     

     

     

    47,182

     

    General and administrative

     

    12,579

     

     

     

    13,976

     

     

     

    44,789

     

     

     

    39,843

     

    Restructuring costs

     

    —

     

     

     

    —

     

     

     

    2,662

     

     

     

    860

     

    Loss from impairment of property and equipment

     

    —

     

     

     

    209

     

     

     

    —

     

     

     

    209

     

    Total operating expenses

     

    29,902

     

     

     

    34,961

     

     

     

    97,152

     

     

     

    106,150

     

    Loss from operations

     

    (8,596

    )

     

     

    (19,152

    )

     

     

    (40,478

    )

     

     

    (63,429

    )

    Other (expense) income, net:

     

     

     

     

     

     

     

    Interest expense

     

    (713

    )

     

     

    —

     

     

     

    (714

    )

     

     

    —

     

    Interest income

     

    436

     

     

     

    628

     

     

     

    1,049

     

     

     

    2,394

     

    Other income (expense), net

     

    (44

    )

     

     

    34

     

     

     

    117

     

     

     

    (33

    )

    Change in fair value of contingent earn-out liability

     

    7,521

     

     

     

    (8,321

    )

     

     

    2,297

     

     

     

    15,092

     

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    2,178

     

     

     

    (2,056

    )

     

     

    (69

    )

     

     

    2,218

     

    Change in fair value of public warrant liability

     

    (2,578

    )

     

     

    (1,576

    )

     

     

    (6,160

    )

     

     

    5,461

     

    Total other income (expense), net

     

    6,800

     

     

     

    (11,291

    )

     

     

    (3,480

    )

     

     

    25,132

     

    Loss before income taxes

     

    (1,796

    )

     

     

    (30,443

    )

     

     

    (43,958

    )

     

     

    (38,297

    )

    Provision for income taxes

     

    —

     

     

     

    —

     

     

    $

    62

     

     

    $

    —

     

    Net loss

    $

    (1,796

    )

     

    $

    (30,443

    )

     

    $

    (44,020

    )

     

    $

    (38,297

    )

    Net (loss) income attributable to common stockholders – basic and diluted

    $

    (1,796

    )

     

    $

    (30,443

    )

     

    $

    (44,020

    )

     

    $

    (38,297

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – basic and diluted

     

    172,790,098

     

     

     

    157,709,229

     

     

     

    166,327,570

     

     

     

    155,760,149

     

    Net loss per share - basic and diluted

    $

    (0.01

    )

     

    $

    (0.19

    )

     

    $

    (0.26

    )

     

    $

    (0.25

    )

     

     

     

     

     

     

     

     

    Net loss

    $

    (1,796

    )

     

    $

    (30,443

    )

     

    $

    (44,020

    )

     

    $

    (38,297

    )

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    26

     

     

     

    (86

    )

     

     

    (105

    )

     

     

    (75

    )

    Total other comprehensive income (loss)

     

    26

     

     

     

    (86

    )

     

     

    (105

    )

     

     

    (75

    )

    Total comprehensive loss

    $

    (1,770

    )

     

    $

    (30,529

    )

     

    $

    (44,125

    )

     

    $

    (38,372

    )

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    September 30, 2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    31,504

     

     

    $

    37,015

     

    Marketable securities

     

    24,723

     

     

     

    14,927

     

    Accounts receivable, net

     

    48,883

     

     

     

    28,392

     

    Inventory

     

    8,770

     

     

     

    16,963

     

    Current portion of contract assets

     

    1,212

     

     

     

    799

     

    Current portion of commission asset

     

    5,956

     

     

     

    5,429

     

    Prepaid expenses and other current assets

     

    30,593

     

     

     

    17,921

     

    Total current assets

     

    151,641

     

     

     

    121,446

     

    Contract assets, noncurrent

     

    381

     

     

     

    657

     

    Commission asset, noncurrent

     

    7,759

     

     

     

    7,567

     

    Property and equipment, net

     

    126,919

     

     

     

    123,661

     

    Operating lease right-of-use assets

     

    12,730

     

     

     

    13,993

     

    Other assets

     

    4,859

     

     

     

    735

     

    Total assets

    $

    304,289

     

     

    $

    268,059

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    4,724

     

     

    $

    10,492

     

    Accrued expenses and other current liabilities

     

    33,954

     

     

     

    19,508

     

    Current portion of deferred revenue

     

    77,904

     

     

     

    64,506

     

    Current portion of operating lease liabilities

     

    2,765

     

     

     

    2,203

     

    Total current liabilities

     

    119,347

     

     

     

    96,709

     

    Deferred revenue, noncurrent

     

    18,464

     

     

     

    20,266

     

    Long-term debt, noncurrent

     

    28,528

     

     

     

    —

     

    Operating lease liabilities, noncurrent

     

    11,107

     

     

     

    12,326

     

    Contingent earn-out liability, noncurrent

     

    10,512

     

     

     

    12,809

     

    Contingently issuable common stock liability, noncurrent

     

    3,638

     

     

     

    4,001

     

    Public warrant liability, noncurrent

     

    10,457

     

     

     

    4,297

     

    Total liabilities

     

    202,053

     

     

     

    150,408

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2025 and December 31, 2024; 173,803,265 and 159,602,069 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively

     

    17

     

     

     

    16

     

    Additional paid-in capital

     

    501,040

     

     

     

    472,331

     

    Accumulated other comprehensive loss

     

    (137

    )

     

     

    (32

    )

    Accumulated deficit

     

    (398,684

    )

     

     

    (354,664

    )

    Stockholders' equity

     

    102,236

     

     

     

    117,651

     

    Total liabilities and stockholders' equity

    $

    304,289

     

     

    $

    268,059

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (44,020

    )

     

    $

    (38,297

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    17,859

     

     

     

    11,933

     

    Write-off of inventory and change in inventory reserve

     

    2,016

     

     

     

    3,151

     

    Loss from impairment of property and equipment

     

    —

     

     

     

    209

     

    Loss on disposal of property and equipment

     

    3,503

     

     

     

    —

     

    Stock-based compensation

     

    15,816

     

     

     

    21,364

     

    Non-cash interest expense

     

    195

     

     

     

    —

     

    Amortization of premium on marketable securities, net of change in accrued interest

     

    10

     

     

     

    261

     

    Non-cash lease expense

     

    1,263

     

     

     

    1,116

     

    Change in allowance for expected credit losses

     

    66

     

     

     

    371

     

    Change in fair value of earn-out liability

     

    (2,297

    )

     

     

    (15,092

    )

    Change in fair value of contingently issuable common stock

     

    69

     

     

     

    (2,218

    )

    Change in fair value of public warrant liability

     

    6,160

     

     

     

    (5,461

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (20,557

    )

     

     

    (13,679

    )

    Inventory

     

    11,079

     

     

     

    (8,327

    )

    Commission assets

     

    (719

    )

     

     

    (1,005

    )

    Contract assets

     

    (137

    )

     

     

    993

     

    Other assets

     

    437

     

     

     

    333

     

    Prepaid expenses and other current assets

     

    (17,331

    )

     

     

    (4,093

    )

    Accounts payable

     

    1,845

     

     

     

    216

     

    Deferred revenue

     

    11,596

     

     

     

    13,559

     

    Accrued expenses and other current liabilities

     

    16,902

     

     

     

    1,655

     

    Operating lease liability

     

    (657

    )

     

     

    (1,046

    )

    Net cash provided by (used in) operating activities

     

    3,098

     

     

     

    (34,057

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (4,311

    )

     

     

    (4,773

    )

    Purchases of property and equipment

     

    (29,109

    )

     

     

    (24,443

    )

    Purchases of marketable securities

     

    (34,481

    )

     

     

    (14,567

    )

    Proceeds from maturities of marketable securities

     

    24,675

     

     

     

    55,635

     

    Net cash (used in) provided by investing activities

     

    (43,226

    )

     

     

    11,852

     

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options

     

    8,406

     

     

     

    1,151

     

    Proceeds from long-term debt

     

    26,316

     

     

     

    —

     

    Net cash provided by financing activities

     

    34,722

     

     

     

    1,151

     

    Effect of exchange rate changes on cash and cash equivalents

     

    (105

    )

     

     

    (75

    )

    Net decrease in cash, cash equivalents and restricted cash

     

    (5,511

    )

     

     

    (21,129

    )

    Cash, cash equivalents and restricted cash

     

     

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    37,015

     

     

     

    67,437

     

    Cash, cash equivalents and restricted cash at end of period

    $

    31,504

     

     

    $

    46,308

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

    Three Months Ended or as of,

    ($ in thousands)

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

    New customers

     

     

    53

     

     

    84

     

     

    52

     

     

    60

     

     

    54

     

     

    63

     

     

    62

    Annual recurring revenue

     

    $

    79,192

     

    $

    87,011

     

    $

    93,676

     

    $

    99,351

     

    $

    105,990

     

    $

    110,516

     

    $

    117,200

    Recurring revenue

     

    $

    18,961

     

    $

    21,016

     

    $

    23,764

     

    $

    23,678

     

    $

    25,753

     

    $

    26,678

     

    $

    30,120

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended,

     

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

     

    (Restated)

     

    (Restated)

     

     

     

     

     

     

     

     

     

     

    Operating expenses, GAAP

     

    $

    34,061

     

     

    $

    37,128

     

     

    $

    34,961

     

     

    $

    35,619

     

     

    $

    33,539

     

     

    $

    33,711

     

     

    $

    29,902

     

    Stock-based compensation

     

     

    (6,292

    )

     

     

    (7,254

    )

     

     

    (7,263

    )

     

     

    (3,159

    )

     

     

    (4,660

    )

     

     

    (5,265

    )

     

     

    (5,121

    )

    Loss on impairment of leased equipment

     

     

    —

     

     

     

    —

     

     

     

    (209

    )

     

     

    (15

    )

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Non-recurring employee restructuring and other separation costs

     

     

    —

     

     

     

    (1,000

    )

     

     

    —

     

     

     

    (2,060

    )

     

     

    (2,137

    )

     

     

    (827

    )

     

     

    (6

    )

    Other non-recurring legal and regulatory costs

     

     

    (476

    )

     

     

    (2,185

    )

     

     

    (2,339

    )

     

     

    (7,284

    )

     

     

    (3,561

    )

     

     

    (5,979

    )

     

     

    36

     

    Adjusted operating expenses

     

    $

    27,293

     

     

    $

    26,689

     

     

    $

    25,150

     

     

    $

    23,101

     

     

    $

    23,181

     

     

    $

    21,640

     

     

    $

    24,811

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue

    $

    42,850

     

     

    $

    27,360

     

     

    $

    107,401

     

     

    $

    74,765

     

    Cost of revenue

     

    21,544

     

     

     

    11,551

     

     

     

    50,727

     

     

     

    32,044

     

    Gross profit, GAAP

     

    21,306

     

     

     

    15,809

     

     

     

    56,674

     

     

     

    42,721

     

    Stock-based compensation

     

    269

     

     

     

    244

     

     

     

    770

     

     

     

    555

     

    Amortization of capitalized stock-based compensation

     

    114

     

     

     

    23

     

     

     

    324

     

     

     

    52

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    —

     

     

     

    6

     

     

     

    —

     

    Non-recurring inventory charges

     

    —

     

     

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

    Adjusted gross profit*

    $

    21,689

     

     

    $

    17,547

     

     

    $

    57,774

     

     

    $

    45,935

     

     

     

     

     

     

     

     

     

    Gross margin %

     

    49.7

    %

     

     

    57.8

    %

     

     

    52.8

    %

     

     

    57.1

    %

    Adjusted gross margin %

     

    50.6

    %

     

     

    64.1

    %

     

     

    53.8

    %

     

     

    61.4

    %

     

    *Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Loss from operations, GAAP

    $

    (8,596

    )

     

    $

    (19,152

    )

     

    $

    (40,478

    )

     

    $

    (63,429

    )

    Stock-based compensation

     

    5,390

     

     

     

    7,507

     

     

     

    15,816

     

     

     

    21,364

     

    Amortization of capitalized stock-based compensation

     

    114

     

     

     

    23

     

     

     

    324

     

     

     

    52

     

    Loss on impairment of lease equipment

     

    —

     

     

     

    209

     

     

     

    —

     

     

     

    209

     

    Non-recurring employee restructuring and other separation costs

     

    6

     

     

     

    —

     

     

     

    2,976

     

     

     

    1,000

     

    Non-recurring inventory charges

     

    —

     

     

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

    Other non-recurring legal and regulatory costs

     

    (36

    )

     

     

    2,339

     

     

     

    9,504

     

     

     

    5,000

     

    Adjusted loss from operations*

    $

    (3,122

    )

     

    $

    (7,603

    )

     

    $

    (11,858

    )

     

    $

    (33,197

    )

     

    *Beginning this quarter, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net loss

    $

    (1,796

    )

     

    $

    (30,443

    )

     

    $

    (44,020

    )

     

    $

    (38,297

    )

    Depreciation & amortization

     

    6,541

     

     

     

    4,575

     

     

     

    17,859

     

     

     

    11,933

     

    Stock-based compensation

     

    5,390

     

     

     

    7,507

     

     

     

    15,816

     

     

     

    21,364

     

    Interest expense (income)

     

    277

     

     

     

    (628

    )

     

     

    (335

    )

     

     

    (2,394

    )

    Provision for income taxes

     

    —

     

     

     

    —

     

     

     

    62

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    (7,521

    )

     

     

    8,321

     

     

     

    (2,297

    )

     

     

    (15,092

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (2,178

    )

     

     

    2,056

     

     

     

    69

     

     

     

    (2,218

    )

    Change in fair value of public warrant liability

     

    2,578

     

     

     

    1,576

     

     

     

    6,160

     

     

     

    (5,461

    )

    Loss on impairment of leased equipment

     

    —

     

     

     

    209

     

     

     

    —

     

     

     

    209

     

    Loss on disposal of leased equipment

     

    1,870

     

     

     

    —

     

     

     

    3,503

     

     

     

    —

     

    Non-recurring employee restructuring and other separation costs

     

    6

     

     

     

    —

     

     

     

    2,976

     

     

     

    1,000

     

    Non-recurring inventory charges

     

    —

     

     

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

    Other non-recurring legal and regulatory costs

     

    (36

    )

     

     

    2,339

     

     

     

    9,504

     

     

     

    5,000

     

    Adjusted EBITDA

    $

    5,131

     

     

    $

    (3,017

    )

     

    $

    9,297

     

     

    $

    (21,349

    )

     

     

     

     

     

     

     

     

    Net profit margin %

     

    (4.2

    )%

     

     

    (111.3

    )%

     

     

    (41.0

    )%

     

     

    (51.2

    )%

    Impact of adjustments from Net loss to Adjusted EBITDA

     

    16.2

    %

     

     

    100.3

    %

     

     

    49.6

    %

     

     

    22.6

    %

    Adjusted EBITDA margin %

     

    12.0

    %

     

     

    (11.0

    )%

     

     

    8.7

    %

     

     

    (28.6

    )%

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net loss

    $

    (1,796

    )

     

    $

    (30,443

    )

     

    $

    (44,020

    )

     

    $

    (38,297

    )

    Stock-based compensation

     

    5,390

     

     

     

    7,507

     

     

     

    15,816

     

     

     

    21,364

     

    Amortization of capitalized stock-based compensation

     

    114

     

     

     

    23

     

     

     

    324

     

     

     

    52

     

    Change in fair value of contingent earn-out liability

     

    (7,521

    )

     

     

    8,321

     

     

     

    (2,297

    )

     

     

    (15,092

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (2,178

    )

     

     

    2,056

     

     

     

    69

     

     

     

    (2,218

    )

    Change in fair value of public warrant liability

     

    2,578

     

     

     

    1,576

     

     

     

    6,160

     

     

     

    (5,461

    )

    Loss on impairment of lease equipment

     

    —

     

     

     

    209

     

     

     

    —

     

     

     

    209

     

    Non-recurring employee restructuring and other separation costs

     

    6

     

     

     

    —

     

     

     

    2,976

     

     

     

    1,000

     

    Non-recurring inventory charges

     

    —

     

     

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

    Other non-recurring legal and regulatory costs

     

    (36

    )

     

     

    2,339

     

     

     

    9,504

     

     

     

    5,000

     

    Adjusted loss

    $

    (3,443

    )

     

    $

    (6,941

    )

     

    $

    (11,468

    )

     

    $

    (30,836

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    172,790,098

     

     

     

    157,709,229

     

     

     

    166,327,570

     

     

     

    155,760,149

     

     

     

     

     

     

     

     

     

    Adjusted loss per share – diluted

    $

    (0.02

    )

     

    $

    (0.04

    )

     

    $

    (0.07

    )

     

    $

    (0.20

    )

     

    *Stock-based compensation, amortization of capitalized stock-based compensation, and non-recurring restructuring and other employee separation costs were recorded in the condensed consolidated statements of operations and comprehensive loss (income) as follows. Prior period amounts are being shown for comparative purposes:

     

    Three Months Ended,

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

    Stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of product revenue

    $

    —

     

    $

    5

     

    $

    4

     

    $

    8

     

     

    $

    8

     

    $

    17

     

    $

    32

    Cost of subscription revenue

     

    91

     

     

    110

     

     

    169

     

     

    154

     

     

     

    137

     

     

    167

     

     

    146

    Cost of service revenue

     

    44

     

     

    51

     

     

    63

     

     

    61

     

     

     

    67

     

     

    74

     

     

    72

    Cost of license fee and other revenue

     

    3

     

     

    7

     

     

    8

     

     

    10

     

     

     

    7

     

     

    24

     

     

    19

    Research and development

     

    902

     

     

    1,222

     

     

    1,243

     

     

    1,153

     

     

     

    1,115

     

     

    1,154

     

     

    1,227

    Sales and marketing

     

    2,959

     

     

    2,724

     

     

    2,516

     

     

    2,747

     

     

     

    1,048

     

     

    1,710

     

     

    1,480

    General and administrative

     

    2,431

     

     

    3,308

     

     

    3,504

     

     

    (741

    )

     

     

    1,972

     

     

    2,401

     

     

    2,414

    Restructuring costs

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

     

    525

     

     

    —

     

     

    —

    Total stock-based compensation

    $

    6,430

     

    $

    7,427

     

    $

    7,507

     

    $

    3,392

     

     

    $

    4,879

     

    $

    5,547

     

    $

    5,390

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Amortization of capitalized stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of subscription revenue

    $

    8

     

    $

    8

     

    $

    13

     

    $

    47

     

     

    $

    59

     

    $

    60

     

    $

    63

    Cost of service revenue

     

    6

     

     

    7

     

     

    10

     

     

    38

     

     

     

    44

     

     

    47

     

     

    51

    Total amortization of capitalized stock-based compensation

    $

    14

     

    $

    15

     

    $

    23

     

    $

    85

     

     

    $

    103

     

    $

    107

     

    $

    114

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Non-recurring employee restructuring and other separation costs:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of service revenue

    $

    —

     

    $

    —

     

    $

    —

     

    $

    —

     

     

    $

    —

     

    $

    6

     

     

    —

    Research and development

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

     

    —

     

     

    31

     

     

    —

    Sales and marketing

     

    —

     

     

    140

     

     

    —

     

     

    63

     

     

     

    —

     

     

    613

     

    $

    6

    General and administrative

     

    —

     

     

    —

     

     

    —

     

     

    1,997

     

     

     

    —

     

     

    183

     

     

    —

    Restructuring costs

     

    —

     

     

    860

     

     

    —

     

     

    —

     

     

     

    2,137

     

     

    —

     

     

    —

    Total non-recurring employee restructuring and other separation costs

    $

    —

     

    $

    1,000

     

    $

    —

     

    $

    2,060

     

     

    $

    2,137

     

    $

    833

     

    $

    6

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251113279465/en/

    Investor Relations:

    Brian Norris

    Senior Vice President of Finance and Investor Relations

    [email protected]

    Get the next $EVLV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    8/15/2025$9.00Hold → Buy
    Lake Street
    8/15/2025$10.00Buy
    TD Cowen
    5/21/2025$7.50Market Perform → Outperform
    Northland Capital
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    More analyst ratings

    $EVLV
    SEC Filings

    View All

    SEC Form 10-Q filed by Evolv Technologies Holdings Inc.

    10-Q - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    11/13/25 4:17:45 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    11/13/25 4:07:16 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Evolv Technologies Holdings Inc.

    SCHEDULE 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    10/30/25 3:19:25 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Glat Neil bought $24,999 worth of shares (8,333 units at $3.00), increasing direct ownership by 5% to 162,355 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    8/14/24 4:05:45 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Gonzales David Mounts bought $150,000 worth of shares (50,000 units at $3.00), increasing direct ownership by 71% to 120,544 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    8/14/24 4:05:10 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Gonzales David Mounts bought $193,000 worth of shares (50,000 units at $3.86) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    3/7/24 5:32:10 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evolv Technology Reports Third Quarter Financial Results

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year — Q3'25 Revenue of $42.9 million, up 57% year-over-year Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)% Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025. "We made meaningful progress across many key measures of the business in the third quarter—including

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Surpasses Over One Million Bags Screened by Evolv eXpedite™

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) is proud to announce that its AI-based bag screening solution, Evolv eXpedite™, has now screened over one million bags since launching last year. Evolv is a leading security technology company pioneering advanced solutions designed to create safer experiences. Evolv's flagship product, Evolv Express®, has screened over 3B people worldwide as part of security operations for iconic venues, leading theme parks and professional sports stadiums as well as school and hospital systems. Evolv eXpedite is an autonomous, high-speed bag screener that uses AI and X-ray imaging to detect potential threats in bags and distinguish them from many everyday i

    11/12/25 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Selects Plexus as New Strategic Contract Manufacturing Partner

    — New Partnership Scales Manufacturing and Global Supply Chain Capabilities — Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it has entered into a strategic contract manufacturing partnership with Plexus Corp. (NASDAQ:PLXS), ("Plexus"). This new partnership helps position the Company to meet growing demand for its industry-leading products while enhancing visibility and coordination across its global supply network. It combines the Company's product expertise with Plexus' design, supply chain and manufacturing capabilities to deliver production and distribu

    11/6/25 8:00:00 AM ET
    $EVLV
    $PLXS
    Computer peripheral equipment
    Technology
    Electrical Products

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Founder & Chief Growth Officer Chitkara Anil exercised 360,000 shares at a strike of $0.28 and sold $2,952,000 worth of shares (360,000 units at $8.20) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    10/28/25 4:03:48 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Ellenbogen Michael sold $666,954 worth of shares (80,745 units at $8.26) and exercised 80,745 shares at a strike of $0.24 (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    10/17/25 4:52:21 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Founder & Chief Innovation Ofc Ellenbogen Michael exercised 80,745 shares at a strike of $0.24 and sold $683,103 worth of shares (80,745 units at $8.46) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    9/17/25 4:02:39 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evolv Technologies Holdings upgraded by Lake Street with a new price target

    Lake Street upgraded Evolv Technologies Holdings from Hold to Buy and set a new price target of $9.00

    8/15/25 8:30:18 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    TD Cowen resumed coverage on Evolv Technologies Holdings with a new price target

    TD Cowen resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $10.00

    8/15/25 8:18:59 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings upgraded by Northland Capital with a new price target

    Northland Capital upgraded Evolv Technologies Holdings from Market Perform to Outperform and set a new price target of $7.50

    5/21/25 8:40:06 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Leadership Updates

    Live Leadership Updates

    View All

    Evolv Extends Partnership with New England Patriots, New England Revolution, and Gillette Stadium

    Extension of original 2021 agreement includes expansion of Evolv Express subscription, and official partnership designations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it renewed its partnership with Gillette Stadium, home of the New England Patriots and New England Revolution. The renewal, which extends a partnership initiated in 2021, increases the number of entry points at which Evolv Express® security screening will be used. All members of the public entering the stadium for football games, soccer matches, concerts, and other events will pass through an

    9/16/25 12:00:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Appoints Chris Kutsor as Chief Financial Officer

    –Evolv Welcomes Proven High-Tech Public Company CFO as Company Enters New Stage of Growth– Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced the appointment of Mr. Chris Kutsor as Chief Financial Officer. The appointment will be effective one business day following the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423812661/en/Chris Kutsor, Chief Financial Officer "We are thrilled to welcome Chris to our le

    4/23/25 8:00:00 AM ET
    $EVLV
    $MSI
    Computer peripheral equipment
    Technology
    Radio And Television Broadcasting And Communications Equipment

    Partnership with Cosm Reinforces Evolv Technology's Sports Industry Position as Innovation Leader

    Evolv brings advanced fan-friendly screening experience to Cosm's initial sites in Los Angeles and Dallas Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it recently entered a partnership with Cosm, the immersive entertainment company pioneering news ways to experience sports and entertainment content. The partnership brings Evolv's advanced Express® systems to Cosm's first two locations, in the Los Angeles and Dallas metro areas. Express will be used to help deliver the secure, fast, and convenient entry screening process at the Cosm sites for major events that p

    4/16/25 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Financials

    Live finance-specific insights

    View All

    Evolv Technology Reports Third Quarter Financial Results

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year — Q3'25 Revenue of $42.9 million, up 57% year-over-year Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)% Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025. "We made meaningful progress across many key measures of the business in the third quarter—including

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Release Third Quarter Financial Results on November 13, 2025

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the third quarter of 2025 on Thursday, November 13, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) is designed to transform human security by helping

    10/6/25 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Reports Second Quarter Financial Results

    — Company Raises Revenue Growth Outlook for 2025 to 27%-30% — Q2'25 Revenue of $32.5 million, up 29% year-over-year Q2'25 Ending ARR1 of $110.5 million, up 27% year-over-year Q2'25 Net Loss of $(40.5) million, with Net Profit Margin of (125)% Q2'25 Adjusted EBITDA2 of $2.0 million, with Adjusted EBITDA Margin2 of 6% Q2'25 Cash Flow from Operations of $2.1 million vs. $(21.6) million in Q2'24 Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended June 30, 2025. "Our second quarter results were marked by strong reve

    8/14/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/12/24 2:31:40 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/7/24 4:31:46 PM ET
    $EVLV
    Computer peripheral equipment
    Technology